61PDGenetic variations within the HER3 gene predict outcome for mCRC patients treated with first-line FOLFIRI/bevacizumab or FOLFIRI/cetuximab: Data from FIRE-3. (23rd October 2018) - Berger, M D; Stintzing, S; Heinemann, V; Cao, S; Yang, D; Miyamoto, Y; Suenaga, M; Hanna, D L; Soni, S; Puccini, A; Tokunaga, R; Naseem, M; et al.